<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=799546403794687&amp;ev=PageView&amp;noscript=1">

CU studying use of patients’ own reprogrammed cells to attack cancer as alternative to more chemo

minute read

by The Denver Post | March 15, 2024
placeholder

A study at University of Colorado’s Gates Institute on the Anschutz Medical Campus is looking at CAR-T in adult patients with acute lymphocytic leukemia, a cancer of the blood and bone marrow, whose first round of chemotherapy either failed or gave a disappointing response that suggests it won’t work for long, executive director Terry Fry, MD, said.

Topics: Press Coverage